Dietary Garcinol Arrests Pancreatic Cancer in p53 and K-ras Conditional Mutant Mouse Model

References

• Freelove R and Walling AD: Pancreatic cancer: diagnosis and management. Am Fam Physician 73, 485–492, 2006.
   PubMed Web of Science ®Google Scholar
• Heinemann V, Haas M, and Boeck S: Systemic treatment of advanced pancreatic cancer. Cancer Treat Rev 38, 843–853, 2012. doi:10.1016/j.ctrv.2011.12.004.
   PubMed Web of Science ®Google Scholar
• Pliarchopoulou K and Pectasides D: Pancreatic cancer: current and future treatment strategies. Cancer Treat Rev 35, 431–436, 2009. doi:S0305-7372(09)00035-8.
   PubMed Web of Science ®Google Scholar
• Tripathi YB, Tripathi P, and Arjmandi BH: Nutraceuticals and cancer management. Front Biosci 10, 1607–1618, 2005.
   PubMed Web of Science ®Google Scholar
• Dhillon N, Aggarwal BB, Newman RA, Wolff RA, Kunnumakkara AB, et al.: Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res 14, 4491–4499, 2008. doi: 14/14/4491 [pii]
   PubMed Web of Science ®Google Scholar
• Jatoi A, Burch P, Hillman D, Vanyo JM, Dakhil S, et al.: A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: results of a Phase II study from the North Central Cancer Treatment Group. Urology 69, 289–294, 2007. doi:S0090-4295(06)02431-9.
   PubMed Web of Science ®Google Scholar
• Parasramka MA, and Gupta SV: Synergistic effect of garcinol and curcumin on antiproliferative and apoptotic activity in pancreatic cancer cells. J Oncol 2012, 709739, 2012. doi:10.1155/2012/709739.
   PubMedGoogle Scholar
• Parasramka MA, Ali S, Banerjee S, Deryavoush T, Sarkar FH, et al.: Garcinol sensitizes human pancreatic adenocarcinoma cells to gemcitabine in association with microRNA signatures. Mol Nutr Food Res, 57, 235–248, 2013. doi:10.1002/mnfr.201200297
   PubMed Web of Science ®Google Scholar
• Padhye S, Ahmad A, Oswal N, and Sarkar FH: Emerging role of Garcinol, the antioxidant chalcone from Garcinia indica Choisy and its synthetic analogs. J Hematol Oncol 2, 38, 2009. doi:10.1186/1756-8722-2-38.
   PubMed Web of Science ®Google Scholar
• Rao AVR, Venkatswamy G, Pendse AD: Camboginol and cambogin. Tetrahedron Lett 21, 1975–1978, 1980.
   Web of Science ®Google Scholar
• Hamed W, Brajeul S, Mahuteau-Betzer F, Thoison O, Mons S, et al.: Oblongifolins A-D, polyprenylated benzoylphloroglucinol derivatives from Garcinia oblongifolia. J Nat Prod 69, 774–777, 2006. doi:10.1021/Np050543s.
   PubMed Web of Science ®Google Scholar
• Fuller RW, Blunt JW, Boswell JL, Cardellina JH, 2nd, and Boyd MR: Guttiferone F, the first prenylated benzophenone from Allanblackia stuhlmannii. J Nat Prod 62, 130–132, 1999. doi:10.1021/np9801514.
   PubMed Web of Science ®Google Scholar
• Saadat N and Gupta SV: Potential role of garcinol as an anticancer agent. J Oncol 2012, 647206, 2012. doi:10.1155/2012/647206.
   PubMedGoogle Scholar
• Tanaka T, Kohno H, Shimada R, Kagami S, Yamaguchi F, et al.: Prevention of colonic aberrant crypt foci by dietary feeding of garcinol in male F344 rats. Carcinogenesis 21, 1183–1189, 2000.
   PubMed Web of Science ®Google Scholar
• Hong J, Sang S, Park HJ, Kwon SJ, Suh N, et al.: Modulation of arachidonic acid metabolism and nitric oxide synthesis by garcinol and its derivatives. Carcinogenesis 27, 278–286, 2006. doi:10.1093/carcin/bgi208.
   PubMed Web of Science ®Google Scholar
• Masullo M, Menegazzi M, Di Micco S, Beffy P, Bifulco G, et al.: Direct interaction of garcinol and related polyisoprenylated benzophenones of Garcinia cambogia fruits with the transcription factor STAT-1 as a likely mechanism of their inhibitory effect on cytokine signaling pathways. J Nat Prod 77, 543–549, 2014. doi:10.1021/np400804y.
   PubMed Web of Science ®Google Scholar
• Prasad S, Ravindran J, Sung B, Pandey MK, and Aggarwal BB: Garcinol potentiates TRAIL-induced apoptosis through modulation of death receptors and antiapoptotic proteins. Mol Cancer Ther 9, 856–868, 2010. doi:10.1158/1535-7163.MCT-09-1113.
   PubMed Web of Science ®Google Scholar
• Hingorani SR, Wang L, Multani AS, Combs C, Deramaudt TB, et al.: Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7, 469–483, 2005. doi:10.1016/j.ccr.2005.04.023.
   PubMed Web of Science ®Google Scholar
• Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, McIntyre D, et al.: Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 324, 1457–1461, 2009. doi:10.1126/science.1171362.
   PubMed Web of Science ®Google Scholar
• Syder AJ, Oh JD, Guruge JL, O’Donnell D, Karlsson M, et al.: The impact of parietal cells on Helicobacter pylori tropism and host pathology: an analysis using gnotobiotic normal and transgenic mice. Proc Natl Acad Sci U S A 100, 3467–3472, 2003. doi:10.1073/pnas.0230380100.
   PubMed Web of Science ®Google Scholar
• Hruban RH, Adsay NV, Albores-Saavedra J, Anver MR, Biankin AV, et al.: Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. Cancer Res 66, 95–106, 2006. doi:10.1158/0008-5472.CAN-05-2168.
   PubMed Web of Science ®Google Scholar
• McKee JS, and Gass JH: Acetaminophen-induced forestomach lesion in normal rats following intravenous exposure. Toxicol Pathol 39, 861–866, 2011. doi:10.1177/0192623311413789.
   PubMed Web of Science ®Google Scholar
• Hirose M, Masuda A, Imaida K, Kagawa M, Tsuda H, et al.: Induction of forestomach lesions in rats by oral administrations of naturally occurring antioxidants for 4 weeks. Jpn J Cancer Res 78, 317–321, 1987.
   PubMedGoogle Scholar
• Nam KT, O’Neal R, Lee YS, Lee YC, Coffey RJ, et al.: Gastric tumor development in Smad3-deficient mice initiates from forestomach/glandular transition zone along the lesser curvature. Lab Invest 92, 883–895, 2012. doi:10.1038/labinvest.2012.47.
   PubMed Web of Science ®Google Scholar
• Fong LY, Ishii H, Nguyen VT, Vecchione A, Farber JL, et al.: p53 deficiency accelerates induction and progression of esophageal and forestomach tumors in zinc-deficient mice. Cancer Res 63, 186–195, 2003.
   PubMed Web of Science ®Google Scholar
• Tsai ML, Chiou YS, Chiou LY, Ho CT, and Pan MH: Garcinol suppresses inflammation-associated colon carcinogenesis in mice. Mol Nutr Food Res 58, 1820–1829, 2014. doi:10.1002/mnfr.201400149.
   PubMed Web of Science ®Google Scholar
• Vivier E, Ugolini S, Blaise D, Chabannon C, and Brossay L: Targeting natural killer cells and natural killer T cells in cancer. Nat Rev Immunol 12, 239–252, 2012. doi:10.1038/nri3174.
   PubMed Web of Science ®Google Scholar
• Smyth MJ, Hayakawa Y, Takeda K, and Yagita H: New aspects of natural-killer-cell surveillance and therapy of cancer. Nat Rev Cancer 2, 850–861, 2002. doi:10.1038/nrc928.
   PubMed Web of Science ®Google Scholar
• Arumugam T, Simeone DM, Van Golen K, and Logsdon CD: S100P promotes pancreatic cancer growth, survival, and invasion. Clin Cancer Res 11, 5356–5364, 2005. doi:10.1158/1078-0432.CCR-05-0092.
   PubMed Web of Science ®Google Scholar
• Dowen SE, Crnogorac-Jurcevic T, Gangeswaran R, Hansen M, Eloranta JJ, et al.: Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer. Am J Pathol 166, 81–92, 2005. doi:10.1016/S0002-9440(10)62234-1.
   PubMed Web of Science ®Google Scholar
• Wilentz RE, Su GH, Dai JL, Sparks AB, Argani P, et al.: Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas: a new marker of DPC4 inactivation. Am J Pathol 156, 37–43, 2000. doi:10.1016/S0002-9440(10)64703-7.
   PubMed Web of Science ®Google Scholar
• Wilentz RE, Iacobuzio-Donahue CA, Argani P, McCarthy DM, Parsons JL, et al.: Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res 60, 2002–2006, 2000.
   PubMed Web of Science ®Google Scholar